The BDNF Val66Met has been suggested to impair activity dependent release of BDNF 12, play a role in BDNF/pro-BDNF secretion ratios 13, and is also associated with increased susceptibility to cognitive deficits and neuropsychiatric disorders 14,15. This evidence concerns the gene BDNF and Cognitive impairment.